Back to CRBP
GOLDMAN SACHS GROUP INC → CRBP
GOLDMAN SACHS GROUP INC CRBP Position History
Corbus Pharmaceuticals Holdings, Inc. • Healthcare
Quarters held
12
Latest value
$153K
Q3 2026
Peak value
$774K
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $197K |
| Q1 2025 | $110K |
| Q2 2025 | $301K |
| Q3 2025 | $422K |
| Q4 2025 | $386K |
| Q4 2025 | $386K |
| Q1 2026 | $774K |
| Q1 2026 | $100K |
| Q2 2026 | $368K |
| Q2 2026 | $221K |
| Q3 2026 | $720K |
| Q3 2026 | $153K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $153K | 22.4K | — | — |
| Q3 2026 | $720K | 105.6K | — | — |
| Q2 2026 | $221K | 23.6K | — | — |
| Q2 2026 | $368K | 39.3K | — | — |
| Q1 2026 | $100K | 10.7K | — | — |
| Q1 2026 | $774K | 82.5K | — | — |
| Q4 2025 | $386K | 47.4K | — | — |
| Q4 2025 | $386K | 47.4K | — | — |
| Q3 2025 | $422K | 33.4K | — | — |
| Q2 2025 | $301K | 43.7K | — | — |
| Q1 2025 | $110K | 20.8K | — | — |
| Q1 2025 | $197K | 37.2K | — | — |